| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.06 | 0.06 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.098 | 0.07 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.07 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.07 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.07 |